Zepp Health Corp

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $23.9m $25.8m $49.5m $82.6m $35.1m $21.6m ($41.8m) ($29.9m) ($75.7m) ($40.1m)
Net Income (Loss) Available to Common Stockholders, Basic ($12.1m) $7.1m $16.5m $82.3m $35.1m $21.6m ($41.8m) ($29.9m) ($75.7m) ($40.1m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $23.9m $25.7m $48.9m $82.4m $35.2m $21.5m ($41.9m) ($29.9m) ($75.8m) ($40.1m)
Net Income (Loss) Attributable to Noncontrolling Interest ($90k) ($542k) ($262k) $146k ($134k) ($100k) ($65k) ($75k)
Depreciation, Depletion and Amortization $6.2m $17.2m $4.2m $8.1m $8.5m $7.7m $5.0m $4.5m
Amortization of Intangible Assets $27k $65k $1.1m $12.2m $16.8m $17.2m $17.7m $2.4m $2.8m
Depreciation $2.4m $544k $840k $1.4m $14.9m $35.1m $41.4m $36.8m $2.6m $1.7m
Deferred Income Tax Expense (Benefit) ($18.5m) ($2.9m) ($4.8m) ($27.8m) ($11.1m) ($20.8m) ($66.3m) ($18.7m) $13.4m $2.2m
Deferred income taxes ($18.5m) ($19.0m) ($32.9m) ($27.8m) ($10.4m) ($18.7m) ($65.2m) ($18.7m) $13.4m $2.2m
Share-based Payment Arrangement, Noncash Expense $57.7m $9.7m $19.6m $7.9m $10.0m $13.0m $7.1m $8.4m $4.8m $2.5m
Share-based Payment Arrangement, Expense $55.1m $65.2m $83.1m $49.1m $59.7m $4.8m $2.5m
Equity Method Investment, Other than Temporary Impairment $0 $0 $4.1m $218k $0 $0 $0 $2.3m $0 $0
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount $0 $2.4m $0 $0 $13.9m $0 $7.3m $0
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0 $0 $0
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $8.0m $0 $0
Impairment of Intangible Assets, Finite-lived $0 $1.1m $0 $0
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $0 $0 $0
Share-based compensation $57.7m $62.8m $134.7m $55.1m $65.2m $83.1m $49.1m $59.7m $4.8m $2.5m
Impairment loss from long-term investments $7.6m $2.6m $13.9m $2.3m $8.2m $1.2m
Impairment loss from short-term investments $320k $0 $0 $1.9m $1.0m
Impairment loss from intangible assets $0 $0 $8.0m $0 $0
Gain (Loss) on Disposition of Property Plant Equipment ($30k) ($4k) ($110k) ($1.1m) $48k $277k ($53k) $56k ($21k)
Income (Loss) from Equity Method Investments ($1.8m) $431k $254k ($160k) ($728k) $6.4m $2.6m $1.2m ($4.2m) ($2.1m)
Income Tax Expense (Benefit) $3.1m $4.2m $7.6m $11.2m $4.8m $1.7m ($9.6m) ($2.2m) $13.7m $2.5m
Interest Expense Nonoperating $5.6m $5.7m
Changes in operating assets and liabilities:
Noncash investing and financing activities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($2.2m) $2.0m $3.8m $18.7m $20.1m $37.6m $21.1m ($35.3m) $5.1m $8.3m
Increase (Decrease) in Inventories $103.5m $8.9m $34.2m $62.2m $62.9m $13.0m ($27.2m) ($51.8m) ($5.6m) $22.1m
Increase (Decrease) in Accounts Payable $272.0m $27.9m $51.8m $134.4m ($1.5m) ($105.6m) ($132.0m) ($27.0m) $14.8m $28.3m
Accounts Receivable, Credit Loss Expense (Reversal) $128k $95k $1.6m $7.5m
Proceeds from Stock Options Exercised $24k $13k $858k
Purchases of property and equipment, accrued but unpaid $10.3m $3.3m $2.5m $4.9m $12.8m $7.2m $1.2m $1.6m $1.4m $516k
Debt and Equity Securities, Unrealized Gain (Loss) $1.9m $7.5m $176k $2.0m $76k
Deconsolidation, Gain (Loss), Amount $8.7m
Gain (Loss) on Investments $1.1m
General and Administrative Expense $102.6m $17.7m $31.1m $35.7m $40.1m $40.5m $34.2m $26.6m $24.9m $29.3m
Goodwill $0 $911k $862k $852k $9.6m $9.6m $9.6m $9.6m $9.6m $9.6m
Inventory Write-down $1.0m $376k $0 $17.7m $59.9m $47.1m
Operating Expenses $262.8m $48.1m $83.4m $123.7m $177.5m $190.1m $175.9m $121.8m $117.5m $128.4m
Realized Investment Gains (Losses) $365k $38k $262k $2.1m $87k $109k
Unrealized Gain (Loss) on Investments $0 $0
Net loss $23.9m $167.1m $336.3m $573.4m $229.7m $137.0m ($289.0m) ($212.6m) ($75.8m) ($40.1m)
Non-cash lease expenses $27.7m $48.2m $41.5m $40.6m $34.3m $1.5m $1.3m
Provision for excess and obsolete inventories $2.4m $0 $23.8m $64.2m $51.3m $39.6m $51.7m $5.2m $7.8m
Gain from fair value change of long-term investments ($7.9m) ($12.3m) ($51.8m) ($1.2m) ($2.0m) ($76k)
Allowance for doubtful accounts $814k $652k $1.6m $7.5m
Realized gain from investments ($2.4m) ($261k) ($1.8m) ($13.5m) ($597k) ($777k)
Accounts receivable $2.2m ($13.2m) ($26.1m) ($130.0m) ($131.2m) ($239.9m) ($145.7m) $250.9m ($5.1m) ($8.3m)
Inventories ($103.5m) ($57.6m) ($234.9m) ($433.0m) ($410.7m) ($83.1m) $187.9m $367.6m $5.6m ($22.1m)
Prepaid expenses and other current assets $6.7m ($33.0m) ($5.7m) ($32.4m) ($80.0m) ($158.8m) $210.8m ($9.4m) ($1.4m) ($16.2m)
Amounts due from related parties ($287.7m) ($109.8m) ($45.1m) ($771.0m) $583.5m $544.6m $166.2m $48.4m $5.5m ($3.2m)
Other non-current assets ($3.1m) ($2.7m) ($33.0m) $8.6m ($30.8m) ($18.5m) $4.5m $333k
Amounts due to related parties ($281k) $5.8m $4.1m ($3.6m) $38.9m ($9.1m) ($16.3m) ($998k) ($1.9m)
Accounts payable $272.0m $181.6m $356.3m $935.8m ($9.8m) ($673.2m) ($910.7m) ($191.9m) $14.8m $28.3m
Notes payable $2.7m $2.6m $13.7m ($16.8m) ($2.2m) $103.8m $42.4m ($38.0m) ($8.6m) $11.6m
Advance from customers $5.9m $4.3m ($4.7m) $38.9m ($2.2m) ($38.3m) ($2.1m) ($480k) ($36k) ($126k)
Income tax payables $21.7m $972k $32.4m $13.8m ($40.1m) ($25.1m) $119k $4.3m ($478k) ($189k)
Accrued expenses and other current liabilities $28.8m $45.6m $119.9m $86.2m ($149.4m) $7.8m ($60.3m) $93.6m ($6.0m) ($4.0m)
Other non-current liabilities $4.9m $51.3m $57.3m $68.7m ($10.1m) ($12.5m) ($160.7m) ($129k) $68k
Purchase of intangible assets ($1.2m) ($88k) ($52.0m) ($11.8m) ($1.2m) ($7.0m) ($1.8m) ($587k) ($87k) ($268k)
Disposal of intangible assets $22.2m $1.1m $471k
Loans provided to related parties ($16.1m) ($5.0m) ($15.5m) ($9.9m)
Disposal of short-term investments $2.1m $10.5m $4.0m $8.9m $275k
Disposal of long-term investments $23.1m $10.5m $20.0m $2.8m $33.0m $4.9m $1.7m
Deconsolidation of a subsidiary and others ($7.7m) $20.0m $60k $2.8m
Bank borrowings received $10.0m $30.0m $20.0m $1.2b $1.5b $838.9m $400.0m $11.0m $65.7m
Repayment of bank borrowings ($10.0m) ($30.0m) ($20.0m) ($643.1m) ($953.4m) ($727.5m) ($735.0m) ($12.6m) ($73.1m)
Repurchase of ordinary shares ($8.2m) ($13.8m) ($53.2m) ($17.8m) ($2.3m) ($1.2m)
Letter of credit factoring received $310.3m $57.2m $5.1m $131.5m
Repayment of letter of credit factoring ($58.6m) ($62.7m) ($97.0m)
Purchase of non-controlling interest ($705k) ($1.1m)
Receivable from the disposal of intangible assets $19.7m $1.7m $1.2m
Conversion from loan to long-term investment $8.0m $17.1m
Payable/(Receivable) for repurchasing of ordinary shares $8.0m $129k $418k ($100k) ($118k)
Net Cash Provided by (Used in) Operating Activities $17.3m $36.6m $102.9m $61.5m $24.1m ($36.5m) ($114.2m) $42.1m ($24.4m) ($25.7m)
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $10.3m $3.3m $2.5m $4.9m $12.8m $7.2m $1.2m $1.6m $1.4m $516k
Payments to Acquire Businesses, Net of Cash Acquired $4.1m
Purchase of long-term investments ($62.9m) ($23.6m) ($109.9m) ($180.9m) ($82.2m) ($1.1b) ($12.7m) ($2.0m) ($7.0m)
Payments for (Proceeds from) Other Investing Activities ($1k)
Net Cash Provided by/(Used in) by Investing Activities ($99.4m) ($38.9m) ($324.8m) ($112.7m) ($206.9m) ($1.1b) ($42.3m) $54.7m ($1.6m) $1.5m
Net Cash Provided by (Used in) Investing Activities ($99.4m) ($6.0m) ($47.2m) ($16.2m) ($31.7m) ($167.8m) ($6.1m) $7.7m ($1.6m) $1.5m
Cash flows from financing activities:
Payments for Repurchase of Common Stock $1.2m $2.2m $7.7m $2.5m $2.3m $1.2m
Payments of Ordinary Dividends, Common Stock $1 $6
Dividends Payable $0
Net Cash (Used in)/Provided by Financing Activities $10.0m $20.1m $639.2m $25.6m $564.7m $551.1m $289.2m ($295.0m) $477k $24.8m
Net Cash Provided by (Used in) Financing Activities $10.0m $3.1m $93.0m $3.7m $86.5m $86.5m $41.9m ($41.6m) $477k $24.8m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.3m ($488k) $8.8m $1.6m ($6.6m) ($2.4m)
Effect of exchange rate changes $5.3m ($3.2m) $60.4m $11.3m ($43.3m) ($15.6m) $4.5m ($34.4m) ($4.2m) $1.6m
Net increase /(decrease) in cash and cash equivalents and restricted cash ($72.1m) $219.5m $1.0b $340.9m $515.1m ($750.6m) ($540.7m) $58.4m ($25.5m) $623k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23.5m $56.8m $211.2m $259.1m $348.8m $236.9m $141.1m $140.5m $110.7m $112.9m
Cash and cash equivalents and restricted cash at beginning of the year $153.2m $369.5m $1.5b $1.8b $2.3b $1.5b $973.3m $997.3m $110.7m $112.9m
Cash and cash equivalents $2k $128.6m $133.7m $91.1m $57.0m
Restricted cash $12.6m $6.8m $19.7m $55.9m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $2.0m $191k $41k $2.3m $7.4m $8.1m $6.2m $89k $1.2m
Income tax (receipt)/paid- Mainland China $9.6m $35.9m $52.1m $91.7m $82.4m $74.4m $3.4m ($1.7m) $62k $293k

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.